AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 78 PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AL)IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP
Authors: BLAISE D REIFFERS J ATTAL M STOPPA AM MARIT G HUGUET F MOLINA L PICO JL GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 78 PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AL)IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP, Bone marrow transplantation, 21, 1998, pp. 368-368
RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP
Authors: BLAISE D ATTAI M REIFFERS J STOPPA AM HUGUET F MARIT G MOLINA L BELLANGER C PICO JL GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP, British Journal of Haematology, 102(1), 1998, pp. 89-89
THE USE OF A SEQUENTIAL HIGH-DOSE RECOMBINANT INTERLEUKIN-2 REGIMEN AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE THE DISEASE-FREE SURVIVAL OF PATIENTS WITH ACUTE-LEUKEMIA TRANSPLANTED IN FIRSTCOMPLETE REMISSION
Authors: BLAISE D ATTAL M PICO JL REIFFERS J STOPPA AM BELLANGER C MOLINA L NEDELLEC G VERNANT JP LEGROS M GABUS R HUGUET F BRANDELY M HERCEND T OLIVE D MARANINCHI D
Citation: D. Blaise et al., THE USE OF A SEQUENTIAL HIGH-DOSE RECOMBINANT INTERLEUKIN-2 REGIMEN AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE THE DISEASE-FREE SURVIVAL OF PATIENTS WITH ACUTE-LEUKEMIA TRANSPLANTED IN FIRSTCOMPLETE REMISSION, Leukemia & lymphoma, 25(5-6), 1997, pp. 469-478
TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH HIGH-DOSE RECOMBINANT INTERLEUKIN-2 - RESULTS OF A PHASE-II STUDY IN 21 PATIENTS
Authors: VEY N BLAISE D OLIVE D LAFAGE M VIENS P BAUME D CAMERLO J STOPPA AM GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: N. Vey et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH HIGH-DOSE RECOMBINANT INTERLEUKIN-2 - RESULTS OF A PHASE-II STUDY IN 21 PATIENTS, Experimental hematology, 25(8), 1997, pp. 481-481
ANALYSIS OF T-CELL IMMUNE-RESPONSE IN RENAL-CELL CARCINOMA - POLARIZATION TO TYPE 1-LIKE DIFFERENTIATION PATTERN, CLONAL T-CELL EXPANSION AND TUMOR-SPECIFIC CYTOTOXICITY
Authors: ANGEVIN E KREMER F GAUDIN C HERCEND T TRIEBEL F
Citation: E. Angevin et al., ANALYSIS OF T-CELL IMMUNE-RESPONSE IN RENAL-CELL CARCINOMA - POLARIZATION TO TYPE 1-LIKE DIFFERENTIATION PATTERN, CLONAL T-CELL EXPANSION AND TUMOR-SPECIFIC CYTOTOXICITY, International journal of cancer, 72(3), 1997, pp. 431-440
IN-SITU T-CELL RESPONSES IN A PRIMARY REGRESSIVE MELANOMA AND SUBSEQUENT METASTASES - A COMPARATIVE-ANALYSIS
Authors: CARCELAIN G ROUASFREISS N ZORN E CHUNGSCOTT V VIEL S FAURE F BOSQ J HERCEND T
Citation: G. Carcelain et al., IN-SITU T-CELL RESPONSES IN A PRIMARY REGRESSIVE MELANOMA AND SUBSEQUENT METASTASES - A COMPARATIVE-ANALYSIS, International journal of cancer, 72(2), 1997, pp. 241-247
MHC-DEPENDENT CYTOLYSIS OF AUTOLOGOUS TUMOR-CELLS BY LYMPHOCYTES INFILTRATING UROTHELIAL CARCINOMAS
Authors: HOUSSEAU F ZELISZEWSKI D ROY M PARADIS V RICHON S RICOUR A BOUGARAN J PRAPOTNICH D VALLANCIEN G BENOIT G DESPORTES L BEDOSSA P HERCEND T BIDART JM BELLET D
Citation: F. Housseau et al., MHC-DEPENDENT CYTOLYSIS OF AUTOLOGOUS TUMOR-CELLS BY LYMPHOCYTES INFILTRATING UROTHELIAL CARCINOMAS, International journal of cancer, 71(4), 1997, pp. 585-594
RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP
Authors: BLAISE D ATTAL M REIFFERS J STOPPA AM HUGUET F MARIT G MOLINA L BELLANGER C PICO JL GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP, Blood, 90(10), 1997, pp. 491-491
A PROSPECTIVE RANDOMIZED STUDY OF R-IL2 AFTER AUTOLOGUOUS BMT FOR ACUTE-LEUKEMIA IN CR-1
Authors: BLAISE D ATTAL M REIFFERS J MOLINA L BELLANGER C PICO JL NEDELEC G VERNANT JP TROUSSARD X LEGROS M GISSELBRECHT C ROSSI JF BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., A PROSPECTIVE RANDOMIZED STUDY OF R-IL2 AFTER AUTOLOGUOUS BMT FOR ACUTE-LEUKEMIA IN CR-1, Experimental hematology, 24(9), 1996, pp. 368-368
DIHYDROOROTATE DEHYDROGENASE IS A TARGET FOR THE BIOLOGICAL EFFECTS OF LEFLUNOMIDE
Authors: WILLIAMSON RA YEA CM ROBSON PA CURNOCK AP GADHER S HAMBLETON AB WOODWARD K BRUNEAU JM HAMBLETON P SPINELLAJAEGLE S MORAND P COURTIN O SAUTES C WESTWOOD R HERCEND T KUO EA RUUTH E
Citation: Ra. Williamson et al., DIHYDROOROTATE DEHYDROGENASE IS A TARGET FOR THE BIOLOGICAL EFFECTS OF LEFLUNOMIDE, Transplantation proceedings, 28(6), 1996, pp. 3088-3091
T-CELL RECEPTOR REPERTOIRE IN NEUROBLASTOMA PATIENTS
Authors: VALTEAU D SCOTT V CARCELAIN G HARTMANN O ESCUDIER B HERCEND T TRIEBEL F
Citation: D. Valteau et al., T-CELL RECEPTOR REPERTOIRE IN NEUROBLASTOMA PATIENTS, Cancer research, 56(2), 1996, pp. 362-369
T-CELL REPERTOIRES IN HEALTHY AND DISEASED HUMAN TISSUES ANALYZED BY T-CELL RECEPTOR BETA-CHAIN CDR3 SIZE DETERMINATION - EVIDENCE FOR OLIGOCLONAL EXPANSIONS IN TUMORS AND INFLAMMATORY DISEASES
Authors: EVEN J LIM A PUISIEUX I FERRADINI L DIETRICH PY TOUBERT A HERCEND T TRIEBEL F PANNETIER C KOURILSKY P
Citation: J. Even et al., T-CELL REPERTOIRES IN HEALTHY AND DISEASED HUMAN TISSUES ANALYZED BY T-CELL RECEPTOR BETA-CHAIN CDR3 SIZE DETERMINATION - EVIDENCE FOR OLIGOCLONAL EXPANSIONS IN TUMORS AND INFLAMMATORY DISEASES, Research in immunology, 146(2), 1995, pp. 65-80
A NOVEL HUMAN PROTEASE SIMILAR TO THE INTERLEUKIN-1-BETA CONVERTING-ENZYME INDUCES APOPTOSIS IN TRANSFECTED CELLS
Authors: FAUCHEU C DIU A CHAN AWE BLANCHET AM MIOSSEC C HERVE F COLLARDDUTILLEUL V GU Y ALDAPE RA LIPPKE JA ROCHER C SU MSS LIVINGSTON DJ HERCEND T LALANNE JL
Citation: C. Faucheu et al., A NOVEL HUMAN PROTEASE SIMILAR TO THE INTERLEUKIN-1-BETA CONVERTING-ENZYME INDUCES APOPTOSIS IN TRANSFECTED CELLS, EMBO journal, 14(9), 1995, pp. 1914-1922
DIHYDROOROTATE DEHYDROGENASE IS A HIGH-AFFINITY BINDING-PROTEIN FOR A77-1726 AND MEDIATOR OF A RANGE OF BIOLOGICAL EFFECTS OF THE IMMUNOMODULATORY COMPOUND
Authors: WILLIAMSON RA YEA CM ROBSON PA CURNOCK AP GADHER S HAMBLETON AB WOODWARD K BRUNEAU JM HAMBLETON P MOSS D THOMSON TA SPINELLAJAEGLE S MORAND P COURTIN O SAUTES C WESTWOOD R HERCEND T KUO EA RUUTH E
Citation: Ra. Williamson et al., DIHYDROOROTATE DEHYDROGENASE IS A HIGH-AFFINITY BINDING-PROTEIN FOR A77-1726 AND MEDIATOR OF A RANGE OF BIOLOGICAL EFFECTS OF THE IMMUNOMODULATORY COMPOUND, The Journal of biological chemistry, 270(38), 1995, pp. 22467-22472
A NEW SCHEDULE OF INTERLEUKIN-2 FOR METASTATIC RENAL-CELL CARCINOMA -THE INSTITUT GUSTAVE-ROUSSY STUDY
Authors: ESCUDIER B FARACE F THEODORE C ANGEVIN E COURT B COUANET D DIETRICH PY CULINE S PALLARDY M HERCEND T DROZ JP
Citation: B. Escudier et al., A NEW SCHEDULE OF INTERLEUKIN-2 FOR METASTATIC RENAL-CELL CARCINOMA -THE INSTITUT GUSTAVE-ROUSSY STUDY, Bulletin du cancer, 82(4), 1995, pp. 296-302
LEUKEMIA-FREE SURVIVAL AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY INTERLEUKIN-2 IN 50 PATIENTS WITH ACUTE-LEUKEMIA IN FIRST REMISSION
Authors: BLAISE D ATTAL M PICO JL REIFFERS J STOPPA AM BELLANGER C MOLINA L NEDELEC G VERNANT JM LEGROS M GABUS R HUGUET F BRANDELY M HERCEND T OLIVE D MARANINCHI D
Citation: D. Blaise et al., LEUKEMIA-FREE SURVIVAL AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY INTERLEUKIN-2 IN 50 PATIENTS WITH ACUTE-LEUKEMIA IN FIRST REMISSION, Blood, 86(10), 1995, pp. 364-364
IMMUNE-RESPONSE IN A PRIMARY REGRESSIVE M ELANOMA NAD ITS SUBSEQUENT GASTRIC METASTASIS
Authors: HERCEND T ZORN E CARCELAIN G ROUAS N
Citation: T. Hercend et al., IMMUNE-RESPONSE IN A PRIMARY REGRESSIVE M ELANOMA NAD ITS SUBSEQUENT GASTRIC METASTASIS, Bulletin de l'Academie nationale de medecine, 179(3), 1995, pp. 677-690
T-CELL RECEPTOR REPERTOIRE IN COLORECTAL ADENOCARCINOMA PATIENTS WITHHEPATIC METASTASES AND ITS CHANGES INDUCED BY PREOPERATIVE ADJUVANT INTERLEUKIN-2 THERAPY
Authors: SAVELIEVA E FARACE F ANGEVIN E ELIAS D ESCUDIER B DUVILLARD P HERCEND T TRIEBEL F
Citation: E. Savelieva et al., T-CELL RECEPTOR REPERTOIRE IN COLORECTAL ADENOCARCINOMA PATIENTS WITHHEPATIC METASTASES AND ITS CHANGES INDUCED BY PREOPERATIVE ADJUVANT INTERLEUKIN-2 THERAPY, Journal of immunotherapy with emphasis on tumor immunology, 16(1), 1994, pp. 66-76
IMMUNOTHERAPY WITH INTERLEUKIN-2 (IL2) AND LYMPHOKINE-ACTIVATED NATURAL-KILLER-CELLS - IMPROVEMENT OF CLINICAL-RESPONSES IN METASTATIC RENAL-CELL CARCINOMA PATIENTS PREVIOUSLY TREATED WITH IL2
Authors: ESCUDIER B FARACE F ANGEVIN E CHARPENTIER F NITENBERG G TRIEBEL F HERCEND T
Citation: B. Escudier et al., IMMUNOTHERAPY WITH INTERLEUKIN-2 (IL2) AND LYMPHOKINE-ACTIVATED NATURAL-KILLER-CELLS - IMPROVEMENT OF CLINICAL-RESPONSES IN METASTATIC RENAL-CELL CARCINOMA PATIENTS PREVIOUSLY TREATED WITH IL2, European journal of cancer, 30A(8), 1994, pp. 1078-1083
INFLUENCE OF HUMAN-LEUKOCYTE ANTIGEN GENES ON TCR-V GENE SEGMENT FREQUENCIES
Authors: GENEVEE C FARACE F CHUNG V DIU A RAFFOUX C CHARRON D HERCEND T TRIEBEL F
Citation: C. Genevee et al., INFLUENCE OF HUMAN-LEUKOCYTE ANTIGEN GENES ON TCR-V GENE SEGMENT FREQUENCIES, International immunology, 6(10), 1994, pp. 1497-1504
TCR GENE SEGMENTS FROM AT LEAST ONE-3RD OF V-ALPHA SUBFAMILIES REARRANGE AT THE DELTA LOCUS
Authors: GENEVEE C CHUNG V DIU A HERCEND T TRIEBEL F
Citation: C. Genevee et al., TCR GENE SEGMENTS FROM AT LEAST ONE-3RD OF V-ALPHA SUBFAMILIES REARRANGE AT THE DELTA LOCUS, Molecular immunology, 31(2), 1994, pp. 109-115
CELLULAR EXPRESSION AND TISSUE DISTRIBUTION OF THE HUMAN LAG-3-ENCODED PROTEIN, AN MHC CLASS-II LIGAND
Authors: HUARD B GAULARD P FAURE F HERCEND T TRIEBEL F
Citation: B. Huard et al., CELLULAR EXPRESSION AND TISSUE DISTRIBUTION OF THE HUMAN LAG-3-ENCODED PROTEIN, AN MHC CLASS-II LIGAND, Immunogenetics, 39(3), 1994, pp. 213-217
T-CELL REPERTOIRE IN PATIENTS WITH B-CHRONIC LYMPHOCYTIC-LEUKEMIA - EVIDENCE FOR MULTIPLE IN-VIVO T-CELL CLONAL EXPANSIONS
Authors: FARACE F ORLANDUCCI F DIETRICH PY GAUDIN C ANGEVIN E COURTIER MH BAYLE C HERCEND T TRIEBEL F
Citation: F. Farace et al., T-CELL REPERTOIRE IN PATIENTS WITH B-CHRONIC LYMPHOCYTIC-LEUKEMIA - EVIDENCE FOR MULTIPLE IN-VIVO T-CELL CLONAL EXPANSIONS, The Journal of immunology, 153(9), 1994, pp. 4281-4290
DIRECT EVIDENCE TO SUPPORT THE IMMUNOSURVEILLANCE CONCEPT IN A HUMAN REGRESSIVE MELANOMA
Authors: MACKENSEN A CARCELAIN G VIEL S RAYNAL MC MICHALAKI H TRIEBEL F BOSQ J HERCEND T
Citation: A. Mackensen et al., DIRECT EVIDENCE TO SUPPORT THE IMMUNOSURVEILLANCE CONCEPT IN A HUMAN REGRESSIVE MELANOMA, The Journal of clinical investigation, 93(4), 1994, pp. 1397-1402
METASTATIC RENAL-CELL CARCINOMA PATIENTS TREATED WITH INTERLEUKIN-2 OR INTERLEUKIN-2 PLUS INTERFERON-GAMMA - IMMUNOLOGICAL MONITORING
Authors: FARACE F PALLARDY M ANGEVIN E HERCEND T ESCUDIER B TRIEBEL F
Citation: F. Farace et al., METASTATIC RENAL-CELL CARCINOMA PATIENTS TREATED WITH INTERLEUKIN-2 OR INTERLEUKIN-2 PLUS INTERFERON-GAMMA - IMMUNOLOGICAL MONITORING, International journal of cancer, 57(6), 1994, pp. 814-821
Risultati: 1-25 | 26-37